Exodus Point Capital Management, LP Dexcom Inc Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Dexcom Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 156,700 shares of DXCM stock, worth $12.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

156,700

Previous 52,033 201.16%

Holding current value

$12.5 Million

Previous $5.9 Million 78.05%

% of portfolio

0.06%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $6.7 Million - $12.1 Million	104,667 Added 201.16%	156,700 $10.5 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $11.8 Million - $15 Million	-106,895 Reduced 67.26%	52,033 $5.9 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $9.6 Million - $11.8 Million	84,009 Added 112.13%	158,928 $22 Million
Q3 2023 Nov 09, 2023	BUY	$86.06 - $137.93 $6.45 Million - $10.3 Million	74,919 New	74,919 $6.99 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $1.88 Million - $2.22 Million	-18,034 Reduced 24.73%	54,880 $6.38 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $5.76 Million - $8.31 Million	67,747 Added 1311.15%	72,914 $8.26 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $9.68 Million - $11.9 Million	-126,785 Reduced 96.08%	5,167 $416,000
Q2 2022 Aug 19, 2022	BUY	$67.99 - $132.89 $8.44 Million - $16.5 Million	124,070 Added 1574.09%	131,952 $9.83 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $479,996 - $664,280	-5,102 Reduced 39.29%	7,882 $4.03 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $263,376 - $330,198	2,028 Added 18.51%	12,984 $6.97 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $748,784 - $1 Million	7,017 Added 178.14%	10,956 $5.99 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $319,019 - $425,136	3,939 New	3,939 $1.68 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $28,470 - $38,142	-365 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $743,354 - $879,089	-7,783 Reduced 95.52%	365 $150,000
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $40,553 - $68,154	-647 Reduced 7.36%	8,148 $3.3 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $117,754 - $186,352	-2,464 Reduced 21.88%	8,795 $2.37 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $700,247 - $1.1 Million	-19,122 Reduced 62.94%	11,259 $2.46 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $977,430 - $1.2 Million	27,510 Added 958.2%	30,381 $4.53 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $88,642 - $123,921	-3,184 Reduced 52.58%	2,871 $430,000
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $169,963 - $231,179	6,055 New	6,055 $721,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Dexcom Inc Transaction History